RecruitingPhase 1NCT07370584

A Safety Study of IVMED-85 Ophthalmic Solution in Healthy Adults

A Randomized, Vehicle-Controlled, Double-Masked Study of the Safety of IVMED-85 Ophthalmic Solution in Healthy Adults

Sponsor

iVeena Delivery Systems, Inc.

Enrollment

36 participants

Start Date

Feb 4, 2026

Study Type

INTERVENTIONAL

Conditions

Safety Study

Summary

The purpose of this trial is to determine the safety of IVMED-85 eye drops in healthy adult subjects. Participants will be assigned to either the active or vehicle eyedrop group. The participants will receive eye drops twice daily for 6 weeks. Participants will not know which eyedrop they are taking.

Eligibility

Min Age: 18 YearsMax Age: 49 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called IVMED-85 ophthalmic solution and a drug called Vehicle Ophthalmic Solution for people with safety study. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 49 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGIVMED-85 ophthalmic solution

IVMED-85 ophthalmic solution (0.20 mg/mL), administer twice a day (morning and evening) in both eyes

DRUGVehicle Ophthalmic Solution

Vehicle ophthalmic solution, administer twice a day (morning and evening) in both eyes

Locations(1)

Total Eye Care, P.A.

Memphis, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07370584